GenDx Biotech Co., Ltd.
In 2007, GenDxbio was founded, which marked the company's initial stage. In 2017, GenDx Biotech was established and acquired GenDxbio in the same year. GenDx Biotech is committed to on-spot pathogens detection solutions with the molecular Point-of-Care Testing (POCT) technology platforms and the comprehensive instrument systems.
Over the past two decades, ERA Technology (Enzymatic Rapid Amplification) and GENEYE systems developed by GenDx Biotech have been highly recongnized as a preferred solution for various pathogens identification in kinds of scenarios.
